Home > Insider Trading > Filing (0001214659-20-010486)

Filing Details

Accession Number:: 0001214659-20-010486
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-12-16 17:37:22
Reporting Period:: 2020-12-14

Accepted Time:: 2020-12-16 17:37:22
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1576263	Mirati Therapeutics Inc.	MRTX	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1225503	A L Bruce Carter	C/O Mirati Therapeutics, Inc 9393 Towne Centre Drive, Ste 200 San Diego CA 92121		No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2020-12-14	2,250	$6.78	4,250	No	4	M	Direct
Common Stock	Disposition	2020-12-14	49	$240.93	4,201	No	4	S	Direct
Common Stock	Disposition	2020-12-14	287	$244.05	3,914	No	4	S	Direct
Common Stock	Disposition	2020-12-14	589	$244.97	3,325	No	4	S	Direct
Common Stock	Disposition	2020-12-14	257	$246.27	3,068	No	4	S	Direct
Common Stock	Disposition	2020-12-14	710	$247.63	2,358	No	4	S	Direct
Common Stock	Disposition	2020-12-14	357	$248.28	2,001	No	4	S	Direct
Common Stock	Disposition	2020-12-14	1	$248.96	2,000	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non Qualified Stock Option (right to buy)	Disposition	2020-12-14	2,250	$0.00	2,250	$6.78

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
4,500	2019-09-27	2026-09-26	No	4	M	Direct

Footnotes

The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 5, 2020
This transaction was executed in multiple trades at prices ranging from $243.50 to $244.49. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $244.54 to $245.23. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $245.855 to $246.42. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $246.88 to $247.76. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $247.90 to $248.81. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.